NCT07320651 Improving Shared Decision-Making in Menstrual Management and Contraception for Adolescents and Young Adults
| NCT ID | NCT07320651 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Geneva |
| Condition | Contraception |
| Study Type | INTERVENTIONAL |
| Enrollment | 252 participants |
| Start Date | 2025-09-02 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 252 participants in total. It began in 2025-09-02 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Decision aids are educational tools designed to help people participate in decision-making about health care choices, by providing evidence-based information, promoting patient-centered care, and supporting patient autonomy and engagement. Our research team developed an Encounter Decision Aid (EDA) exploring treatment options for menstrual management in adolescents and young adults (AYAs), in accordance with the latest International Patient Decision Aids Standards and the Ottawa Decision Support Framework. In this cluster-randomized controlled trial, we aim to evaluate the effectiveness of this EDA on patient-centered outcome measures in AYAs considering treatment for menstrual management and/or contraception compared to standard counseling.
Eligibility Criteria
Inclusion Criteria: * adolescents and young adults aged 12-25 years old * presenting to an outpatient consultation at "Unité de policlinique de gynécologie" or "Consultation de gynécologie pédiatrique" at HUG * considering initiation or switch to hormonal medication for menstrual management and/or contraception * able to give informed consent as documented by signature or accompanied by a legal guardian who can provide consent if required. Exclusion Criteria: * individuals who cannot read and understand French to a degree that would prevent participation in informed consent and study-related materials. * individuals who have major sensory disability, such as visual or hearing impairment, that would compromise their ability to give written informed consent and use the EDA, in the absence of their legal guardian. * individuals with cognitive or psychiatric conditions significantly impairing decision making capacity, unless accompanied by a legal guardian. * patients currently participating in another clinical trial related to contraceptive decision-making, to avoid potential interference.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07320651 clinical trial?
This trial is open to female participants only, aged 12 Years or older, up to 25 Years, studying Contraception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07320651 currently recruiting?
Yes, NCT07320651 is actively recruiting participants. Contact the research team at dehlia.moussaoui@hug.ch for enrollment information.
Where is the NCT07320651 trial being conducted?
This trial is being conducted at Geneva, Switzerland.
Who is sponsoring the NCT07320651 clinical trial?
NCT07320651 is sponsored by University Hospital, Geneva. The trial plans to enroll 252 participants.